The Women's and Children's Hospital is located on King William Road in North Adelaide, Australia. It is one of the major hospitals in Adelaide and is a teaching hospital of the University of Adelaide, the University of South Australia and Flinders University.

There are 314 beds in Women's and Children's Hospital.

During the past decade, Women's and Children's Hospital conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 39 clinical trials were completed, i.e. on average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 17 clinical trials were completed. i.e. 73.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's and Children's Hospital" #1 sponsor was "Children's Oncology Group" with 67 trials, followed by "National Cancer Institute (NCI)" with 11 trials sponsored, "Murdoch Childrens Research Institute" with 5 trials sponsored, "Pfizer" with 4 trials sponsored and "BioMarin Pharmaceutical" with 4 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's and Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Royal Children's Hospital" with 4 trials as a collaborator, "Abeona Therapeutics, Inc" with 3 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator. Other collaborators include 93 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Women's and Children's Hospital" are "Sarcoma" (9 trials), "Leukemia" (8 trials), "Neuroblastoma" (6 trials), "Acute Lymphoblastic Leukemia" (5 trials) and "Cystic Fibrosis" (4 trials). Many other conditions were trialed in "Women's and Children's Hospital" in a lesser frequency.

Most popular intervention types in "Women's and Children's Hospital" are "Drug" (98 trials), "Biological" (46 trials), "Other" (42 trials), "Radiation" (36 trials) and "Procedure" (28 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Cyclophosphamide" (21 trials), "Vincristine Sulfate" (21 trials), "Doxorubicin Hydrochloride" (17 trials) and "cyclophosphamide" (17 trials). Other intervention names were less common.

The vast majority of trials in "Women's and Children's Hospital" are 138 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Women's and Children's Hospital". undefined are not yet recruiting, 26 are recruiting, 34 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 69 completed trials in Women's and Children's Hospital, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Women's and Children's Hospital, 13 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".

Women's and Children's Hospital has several departments that took part in Clinical trials: "Womens and Childrens Hospital; Department of Gastroenterology" - 2 trials